TEM
0.007
40%
IMC
0.04
-33.3%
FBR
0.004
33.3%
TSK
0.105
-30%
LRM
0.032
33.3%
CPO
0.012
-20%
PIL
0.004
33.3%
PGY
0.004
-20%
PRM
0.004
33.3%
HMI
0.035
-18.6%
QXR
0.004
33.3%
CGS
2.06
-17.9%
TRP
0.42
31.3%
AYT
0.005
-16.7%
FCT
0.009
28.6%
IFG
0.01
-16.7%
VAR
0.006
20%
NOR
0.012
-14.3%
ASL
2.2
17.6%
RAU
0.22
-13.7%
PHO
0.14
16.7%
ORN
0.019
-13.6%
RGL
0.007
16.7%
WHK
0.007
-12.5%
VRC
0.007
16.7%
PET
0.015
-11.8%
ALB
0.064
16.4%
RNT
0.045
-11.8%
IVR
0.079
16.2%
ROC
0.15
-11.8%
FTI
0.22
15.8%
NVQ
0.023
-11.5%
MRD
0.038
15.2%
CTE
1.005
-11.1%
AVM
0.115
15%
AM5
0.008
-11.1%
LMG
0.023
15%
NZK
0.16
-11.1%
IPB
0.008
14.3%
AUR
0.025
-10.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH